Skip to main content

Advertisement

Log in

Gastrointestinal Disorders Associated with Common Variable Immune Deficiency (CVID) and Chronic Granulomatous Disease (CGD)

  • Small Intestine (D Sachar, Section Editor)
  • Published:
Current Gastroenterology Reports Aims and scope Submit manuscript

Abstract

Common variable immune deficiency (CVID) and chronic granulomatous disease (CGD) are two of the well-characterized primary immune deficiencies with distinct pathologic defects. While CVID is predominantly a disorder of the adaptive immune system, in CGD, innate immunity is impaired. In both syndromes, the clinical manifestations include an increased susceptibility to infections and a number of non-infectious, inflammatory conditions including systemic autoimmunity, as well as organ-specific pathology. Among the organ-associated disorders, gastrointestinal (GI) manifestations are one of the most intractable. As such, non-infectious inflammatory disorders of the GI tract are clinically challenging as they have protean manifestations, often resembling inflammatory bowel disease (IBD) or celiac disease, are notoriously difficult to treat, and hence are associated with significant morbidity and mortality. Therefore, assessing the pathogenesis and defining appropriate therapeutic approaches for GI disease in patients with CVID and CGD is imperative.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: •• Of major importance

  1. Bonilla FA, Barlan I, Chapel H, Costa-Carvalho BT, Cunningham-Rundles C, de la Morena MT, et al. ICON: common variable immunodeficiency disorders. J Allergy Clin Immunol Pract. 2016;4(1):38–59.

    Article  PubMed  Google Scholar 

  2. Picard C, Al-Herz W, Bousfiha A, Casanova J-L, Chatila T, Conley ME, et al. Primary immunodeficiency diseases: an update on the classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency 2015. J Clin Immunol. 2015. Epub ahead of print.

  3. Resnick ES, Moshier EL, Godbold JH, Cunningham-Rundles C. Morbidity and mortality in common variable immune deficiency over 4 decades. Blood. 2012;119:1650–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Salzer U, Warnatz K, Peter HH. Common variable immunodeficiency: an update. Arthritis Res Ther. 2012;14:223.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Oksenhendler E, Gérard L, Fieschi C, Malphettes M, Mouillot G, Jaussaud R, et al. Infections in 252 patients with common variable immunodeficiency. Clin Infect Dis. 2008;46:1547–54.

    Article  PubMed  Google Scholar 

  6. Malamut G, Verkarre V, Suarez F, Viallard J-F, Lascaux A-S, Cosnes J, et al. The enteropathy associated with common variable immunodeficiency: the delineated frontiers with celiac disease. Am J Gastroenterol. 2010;105:2262–75. ••50 patients with CVID-associated GI symptoms were assessed with chronic diarrhea as the most frequent clinical feature (92%). Pathological small bowel assessment was remarkable for the high frequency of increased IEL (75%) and villous atrophy (50%) whereas plasma cells were almost always absent. IVIg desmonstrated no effect on GI symptoms.

    Article  CAS  PubMed  Google Scholar 

  7. Daniels JA, Lederman HM, Maitra A, Montgomery EA. Gastrointestinal tract pathology in patients with common variable immunodeficiency (CVID): a clinicopathologic study and review. Am J Surg Pathol. 2007;31:1800–12.

    Article  PubMed  Google Scholar 

  8. Kralickova P, Mala E, Vokurkova D, Krcmova I, Pliskova L, Stepanova V, et al. Cytomegalovirus disease in patients with common variable immunodeficiency: three case reports. Int Arch Allergy Immunol. 2014;163:69–74.

    Article  PubMed  Google Scholar 

  9. Salcedo J, Keates S, Pothoulakis C, Warny M, Castagliuolo I, LaMont JT, et al. Intravenous immunoglobulin therapy for severe Clostridium difficile colitis. Gut. 1997;41:366–70.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Woodward JM, Gkrania-Klotsas E, Cordero-Ng AY, Aravinthan A, Bandoh BN, Liu H, et al. The role of chronic norovirus infection in the enteropathy associated with common variable immunodeficiency. Am J Gastroenterol Nature Publishing Group. 2015;110:320–7. ••Stools and small bowel biopsies from 8 CVID patients with CE were analysed by PCR for the presence of Norovirus RNA and compared to 10 CVID patients without GI disorder. All 8 patients with CVID-associated CE showed evidence of chronic Norovirus carriage (none in the control group). Remarkably, 3 patients with Norovirus clearance (one spontaneously, 2 with Ribavirin therapy) exhibited complete symptomatic and histological recovery.

    Article  CAS  Google Scholar 

  11. van de Ven AAJM, Janssen WJM, Schulz LS, van Loon AM, Voorkamp K, Sanders EAM, et al. Increased prevalence of gastrointestinal viruses and diminished secretory immunoglobulin a levels in antibody deficiencies. J Clin Immunol. 2014;34:962–70.

    Article  PubMed  Google Scholar 

  12. Maarschalk-Ellerbroek L, Oldenburg B, Mombers I, Hoepelman A, Brosens L, Offerhaus G, et al. Outcome of screening endoscopy in common variable immunodeficiency disorder and X-linked agammaglobulinemia. Endoscopy. 2013;45:320–3.

    Article  CAS  PubMed  Google Scholar 

  13. Roberts SE, Morrison-Rees S, Samuel DG, Thorne K, Akbari A, Williams JG. Review article: the prevalence of Helicobacter pylori and the incidence of gastric cancer across Europe. Aliment Pharmacol Ther. 2016;43(3):334–45.

    Article  CAS  PubMed  Google Scholar 

  14. Everhart JE, Kruszon-Moran D, Perez-Perez GI, Tralka TS, McQuillan G. Seroprevalence and ethnic differences in Helicobacter pylori infection among adults in the United States. J Infect Dis. 2000;181:1359–63.

    Article  CAS  PubMed  Google Scholar 

  15. Zullo A, Romiti A, Rinaldi V, Vecchione A, Tomao S, Aiuti F, et al. Gastric pathology in patients with common variable immunodeficiency. Gut. 1999;45:77–81.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Desar IME, van Deuren M, Sprong T, Jansen JBMJ, Namavar F, Vandenbroucke-Grauls CM, et al. Serum bactericidal activity against Helicobacter pylori in patients with hypogammaglobulinaemia. Clin Exp Immunol. 2009;156:434–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Washington K, Stenzel TT, Buckley RH, Gottfried MR. Gastrointestinal pathology in patients with common variable immunodeficiency and X-linked agammaglobulinemia. Am J Surg Pathol. 1996;20:1240–52.

    Article  CAS  PubMed  Google Scholar 

  18. Agarwal S, Smereka P, Harpaz N, Cunningham-Rundles C, Mayer L. Characterization of immunologic defects in patients with common variable immunodeficiency (CVID) with intestinal disease. Inflamm Bowel Dis. 2011;17:251–9.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Chapel H, Lucas M, Lee M, Bjorkander J, Webster D, Grimbacher B, et al. Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood. 2008;112:277–86.

    Article  CAS  PubMed  Google Scholar 

  20. Gathmann B, Mahlaoui N, Gérard L, Oksenhendler E, Warnatz K, Schulze I, et al. Clinical picture and treatment of 2212 patients with common variable immunodeficiency. J Allergy Clin Immunol. 2014;134:116–26.e11.

  21. Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol. 1999;92:34–48.

    Article  CAS  PubMed  Google Scholar 

  22. Mannon PJ, Fuss IJ, Dill S, Friend J, Groden C, Hornung R, et al. Excess IL-12 but not IL-23 accompanies the inflammatory bowel disease associated with common variable immunodeficiency. Gastroenterology. 2006;131:748–56.

    Article  CAS  PubMed  Google Scholar 

  23. Baumgart DC, Sandborn WJ. Crohn’s disease. Lancet Elsevier Ltd. 2012;380:1590–605.

    Article  Google Scholar 

  24. Mannon PJ, Fuss IJ, Mayer L, Elson CO, Sandborn WJ, Present D, et al. Anti-interleukin-12 antibody for active Crohn’s disease. N Engl J Med. 2004;351:2069–79.

    Article  CAS  PubMed  Google Scholar 

  25. Sandborn WJ, Gasink C, Gao L-L, Blank MA, Johanns J, Guzzo C, et al. Ustekinumab induction and maintenance therapy in refractory Crohn’s disease. N Engl J Med. 2012;367:1519–28.

    Article  CAS  PubMed  Google Scholar 

  26. Peters CP, Mjösberg JM, Bernink JH, Spits H. Innate lymphoid cells in inflammatory bowel diseases. Immunol Lett. 2015; doi: 10.1016/j.imlet.2015.10.004.

  27. Cols M, Rahman A, Maglione PJ, Garcia-Carmona Y, Simchoni N, Ko H-BM, et al. Expansion of inflammatory innate lymphoid cells in patients with common variable immune deficiency. J Allergy Clin Immunol. 2015; ••Lymphoid cells were identified and analyzed from peripheral blood and GI tissue of CVID patients (31 with and 24 without inflammatory/autoimmune complications). In the blood of CVID patients with inflammatory associated disorders, type 3 ILC and -associated cytokines were expanded. Moreover, numerous IFNγ + RORγt + CD3 - were found in GI biopsies of patients with IBD-like suggesting a role in this mucosal inflammation.

  28. Sanges M, Spadaro G, Miniero M, Mattera D, Sollazzo R, D’Armiento FP, et al. Efficacy of subcutaneous immunoglobulins in primary immunodeficiency with Crohn’s-like phenotype: report of a case. Eur Rev Med Pharmacol Sci. 2015;19:2641–5.

    CAS  PubMed  Google Scholar 

  29. Pignata C, Budillon G, Monaco G, Nani E, Cuomo R, Parrilli G, et al. Jejunal bacterial overgrowth and intestinal permeability in children with immunodeficiency syndromes. Gut. 1990;31:879–82.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Biagi F, Bianchi PI, Zilli A, Marchese A, Luinetti O, Lougaris V, et al. The significance of duodenal mucosal atrophy in patients with common variable immunodeficiency: a clinical and histopathologic study. Am J Clin Pathol. 2012;138:185–9.

    Article  PubMed  Google Scholar 

  31. Boursiquot J-N, Gérard L, Malphettes M, Fieschi C, Galicier L, Boutboul D, et al. Granulomatous disease in CVID: retrospective analysis of clinical characteristics and treatment efficacy in a cohort of 59 patients. J Clin Immunol. 2013;33:84–95.

    Article  CAS  PubMed  Google Scholar 

  32. Ardeniz O, Cunningham-Rundles C. Granulomatous disease in common variable immunodeficiency. Clin Immunol. 2009;133:198–207.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Chase NM, Verbsky JW, Hintermeyer MK, Waukau JK, Tomita-Mitchell A, Casper JT, et al. Use of combination chemotherapy for treatment of granulomatous and lymphocytic interstitial lung disease (GLILD) in patients with common variable immunodeficiency (CVID). J Clin Immunol. 2012;33:30–9.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Cunningham-Rundles C. The many faces of common variable immunodeficiency. Hematol Am Soc Hematol Educ Program. 2012;2012:301–5.

    Google Scholar 

  35. Sander CA, Medeiros LJ, Weiss LM, Yano T, Sneller MC, Jaffe ES. Lymphoproliferative lesions in patients with common variable immunodeficiency syndrome. Am J Surg Pathol. 1992;16:1170–82.

    Article  CAS  PubMed  Google Scholar 

  36. Dhalla F, da Silva SP, Lucas M, Travis S, Chapel H. Review of gastric cancer risk factors in patients with common variable immunodeficiency disorders, resulting in a proposal for a surveillance programme. Clin Exp Immunol. 2011;165:1–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Cassaro M, Rugge M, Gutierrez O, Leandro G, Graham DY, Genta RM. Topographic patterns of intestinal metaplasia and gastric cancer. Am J Gastroenterol. 2000;95:1431–8.

    Article  CAS  PubMed  Google Scholar 

  38. De Petris G, Dhungel BM, Chen L, Chang Y-HH. Gastric adenocarcinoma in common variable immunodeficiency: features of cancer and associated gastritis may be characteristic of the condition. Int J Surg Pathol. 2014;22:600–6.

    Article  PubMed  Google Scholar 

  39. Chua I, Standish R, Lear S, Harbord M, Eren E, Raeiszadeh M, et al. Anti-tumour necrosis factor-alpha therapy for severe enteropathy in patients with common variable immunodeficiency (CVID). Clin Exp Immunol. 2007;150:306–11.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Vázquez-Morón JM, Pallarés-Manrique H, Martín-Suárez IJ, Benítez-Rodríguez B, Ramos-Lora M. Crohn’s-like disease in a patient with common variable immunodeficiency treated with azathioprine and adalimumab. Rev Esp Enferm Dig. 2013;105:299–302.

    Article  PubMed  Google Scholar 

  41. Holland SM. Chronic granulomatous disease. Hematol Oncol Clin North Am. 2013;27:89–99. viii.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Winkelstein JA, Marino MC, Johnston RB, Boyle J, Curnutte J, Gallin JI, et al. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore). 2000;79:155–69.

    Article  CAS  Google Scholar 

  43. van den Berg JM, van Koppen E, Ahlin A, Belohradsky BH, Bernatowska E, Corbeel L, et al. Chronic granulomatous disease: the European experience. PLoS One. 2009;4:e5234.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Jones LBKR, McGrogan P, Flood TJ, Gennery AR, Morton L, Thrasher A, et al. Special article: chronic granulomatous disease in the United Kingdom and Ireland: a comprehensive national patient-based registry. Clin Exp Immunol. 2008;152:211–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Martire B, Rondelli R, Soresina A, Pignata C, Broccoletti T, Finocchi A, et al. Clinical features, long-term follow-up and outcome of a large cohort of patients with chronic granulomatous disease: an Italian multicenter study. Clin Immunol. 2008;126:155–64.

    Article  CAS  PubMed  Google Scholar 

  46. Raptaki M, Varela I, Spanou K, Tzanoudaki M, Tantou S, Liatsis M, et al. Chronic granulomatous disease: a 25-year patient registry based on a multistep diagnostic procedure, from the referral center for primary immunodeficiencies in Greece. J Clin Immunol. 2013;33:1302–9.

    Article  PubMed  Google Scholar 

  47. Magnani A, Brosselin P, Beauté J, de Vergnes N, Mouy R, Debré M, et al. Inflammatory manifestations in a single-center cohort of patients with chronic granulomatous disease. J Allergy Clin Immunol. 2014;134:655–62.e8. ••68 on 98 analyzed CGD patients experienced inflammatory episodes. GI tract was the most commonly affected organ (88% of episodes) and patients with X-linked CGD were at higher risk of inflammatory episodes compared to patients with autosomal-recessive CGD (RR 2.2, 95% CI = 1.5-3.5).

  48. Huang A, Abbasakoor F, Vaizey CJ. Gastrointestinal manifestations of chronic granulomatous disease. Colorectal Dis. 2006;8:637–44.

    Article  CAS  PubMed  Google Scholar 

  49. Marciano BE, Rosenzweig SD, Kleiner DE, Anderson VL, Darnell DN, Anaya-O’Brien S, et al. Gastrointestinal involvement in chronic granulomatous disease. Pediatrics. 2004;114:462–8.

    Article  PubMed  Google Scholar 

  50. Yu JE, De Ravin SS, Uzel G, Landers C, Targan S, Malech HL, et al. High levels of Crohn’s disease-associated anti-microbial antibodies are present and independent of colitis in chronic granulomatous disease. Clin Immunol. Elsevier Inc.; 2011;138:14–22.

  51. Greenberg DE, Ding L, Zelazny AM, Stock F, Wong A, Anderson VL, et al. A novel bacterium associated with lymphadenitis in a patient with chronic granulomatous disease. PLoS Pathog. 2006;2:e28.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Marks DJB, Miyagi K, Rahman FZ, Novelli M, Bloom SL, Segal AW. Inflammatory bowel disease in CGD reproduces the clinicopathological features of Crohn’s disease. Am J Gastroenterol. 2009;104:117–24.

    Article  CAS  PubMed  Google Scholar 

  53. Alimchandani M, Lai J-P, Aung PP, Khangura S, Kamal N, Gallin JI, et al. Gastrointestinal histopathology in chronic granulomatous disease: a study of 87 patients. Am J Surg Pathol. 2013;37:1365–72.

    Article  PubMed  PubMed Central  Google Scholar 

  54. Khangura SK, Kamal N, Ho N, Quezado M, Zhao X, Marciano B, et al. Gastrointestinal features of chronic granulomatous disease found during endoscopy. Clin Gastroenterol Hepatol. Elsevier Ltd; 2015; ••211 GI tract endoscopies were performed at the NIH on 78 CGD patients.. Inflammatory lesions were frequent in all parts of the GI tract with a classically skip pattern. Ano-rectal area was the most often involved GI tract part (93% of patients with colonic inflammation) including sometimes fistulae.

  55. Noel N, Mahlaoui N, Blanche S, Suarez F, Coignard-Biehler H, Durieu I, et al. Efficacy and safety of thalidomide in patients with inflammatory manifestations of chronic granulomatous disease: a retrospective case series. J Allergy Clin Immunol. 2013;132:997–1000. e1–4.

    Article  CAS  PubMed  Google Scholar 

  56. Rosh JR, Tang HB, Mayer L, Groisman G, Abraham SK, Prince A. Treatment of intractable gastrointestinal manifestations of chronic granulomatous disease with cyclosporine. J Pediatr. 1995;126:143–5.

    Article  CAS  PubMed  Google Scholar 

  57. Uzel G, Orange JS, Poliak N, Marciano BE, Heller T, Holland SM. Complications of tumor necrosis factor-α blockade in chronic granulomatous disease-related colitis. Clin Infect Dis. 2010;51:1429–34.

    Article  PubMed  PubMed Central  Google Scholar 

  58. Myrup B, Valerius NH, Mortensen PB. Treatment of enteritis in chronic granulomatous disease with granulocyte colony stimulating factor. Gut. 1998;42:127–30.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Güngör T, Teira P, Slatter M, Stussi G, Stepensky P, Moshous D, et al. Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study. Lancet (London, England). 2014;383:436–48.

    Article  Google Scholar 

Download references

Acknowledgement

This work was supported by the National Institutes of Health AI 101093, AI-086037, AI-48693, T32-GM007280; The Jeffrey Modell Foundation; and the David S Gottesman Immunology Chair (all for CCR), and 5R01DA033777 (SM).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Charlotte Cunningham-Rundles.

Ethics declarations

Conflicts of Interest

MU, HMK, SM, and CCR declare that they have no conflicts of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Small Intestine

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Uzzan, M., Ko, H.M., Mehandru, S. et al. Gastrointestinal Disorders Associated with Common Variable Immune Deficiency (CVID) and Chronic Granulomatous Disease (CGD). Curr Gastroenterol Rep 18, 17 (2016). https://doi.org/10.1007/s11894-016-0491-3

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11894-016-0491-3

Keywords

Navigation